Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms associate… [+17524 chars]Read More
FDA approves Zepbound tirzepatide as the first and only prescription medicine for moderatetosevere obstructive sleep apnea in adults with obesity Investors Eli Lilly and Company
